Clinical trial
Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells
NCT01267461 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells
- Lead sponsor
- Meir Medical Center
- Phase
- Expanded access
- Overall status
- Available
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
colon cancer, endometrial cancer